Follow RSS for latest reports on this topicCervical Cancer - Market Research and Reports

Cervical cancer is a malignant neoplasm of the cervix uteri or cervical area. Symptoms include vaginal bleeding, but may not present until later stages of the cancer. Cervical cancer can be treated using surgery (including local excision) in early stages or chemotherapy and radiotherapy if the disease has been caught later.

Screening for Cervical cancers uses Pap smears, which identify potentially precancerous changes. In developed countries, it is thought to have reduced the incidence of invasive cervical cancer by 50% or more.

The importance of Human papillomavirus (HPV) infection in the development of almost all cases of cervical cancer has led to the development of HPV vaccines effective against the two strains of HPV that currently cause approximately 70% of cervical cancer.

Source; Adapted from Wikipedia

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...



or can supply a pro-forma invoice if required.

Related Reports:

We found over 40 reports that matched your search.

Next 40 Matches >

Refine your search, and find more matches, using the form above.

Colposcopy Market by Instrument Type (Optical, Digital), Portability (Fixed, Portable, Handheld), Application (Cervical Cancer Diagnosis, Physical Examination), End User (Hospitals, Clinics, Diagnostic Centres), and Region - Global Forecast to 2023 [Report Updated: 06-03-2018]

“The global colposcopy market projected to grow at a CAGR of 6.8% during the forecast period”The colposcopy market is expected to reach USD 740.1 million by 2023 from USD 532.6 million in 2018, at a CAGR of 6.8%. Market growth can largely be attributed to factors such as the heavy burden of cervical cancer, rapidly growing geriatric population, and the technological advancements in colposcopy....Read More >>>

Published:
2018-03-06

Published by: MarketsandMarkets

Prices Starting From:
$5650

Oncology Drugs Market Global Report 2017 Including: Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Non-Small Cell Lung Cancer , Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Others (Kaposi Sarcoma, Aids-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicula [Report Updated: 17-07-2017]

Oncology Drugs market covers drugs that are used in the treatment of a wide range of cancer, sarcoma, and tumor. Some of the bestselling oncology drugs in 2016 include Avastin, Herceptin, Revlimid, MabThera/Rituxan, Gleevac/Glivec, Alimta, Zytiga, Tasigna, Sandostatin, and Afinitor.


The global oncology drugs market was estimated to be around 8 billion as of 2016. The oncology drugs market market made up around 11% Read More >>>

Published:
2017-07-17

Published by: The Business Research Company

Prices Starting From:
$4000

Cancer Immunotherapy Market by Technology (Monoclonal Antibodies, Cytokines & Immunomodulators, and Others), by Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others) by End User (Hospitals, Cancer Research Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2014-2022 [Report Updated: 18-05-2017]

CHAPTER 1 INTRODUCTION1.1. REPORT DESCRIPTION1.2. KEY BENEFITS1.3. KEY MARKET SEGMENT1.4. RESEARCH METHODOLOGY1.4.1. Secondary research1.4.2. Primary research1.5. ANALYST TOOLS AND MODELSCHAPTER 2 EXECUTIVE SUMMARY2.1. KEY FINDINGS OF THE STUDY2.2. CXO PERSPECTIVECHAPTER 3 MARKET OVERVIEW3.1. MARKET DEFINITION AND SCOPE3.2. KEY FINDINGS3.2.1. Top investment pockets3.2.2. Top winning strategies3.3....Read More >>>

Published:
2017-05-18

Published by: Allied Market Research

Prices Starting From:
$5370

Cancer Biomarkers Market by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, and Cytogenetics Based Tests), Biomolecules (Genetic Biomarkers, Protein Biomarkers, and Glycoprotein Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, and Other Cancers), Application (Diagnostics, Drug Discovery and Development, Prognosti [Report Updated: 01-12-2016]

Cancer biomarkers are biomolecules that specifies the existence of cancer or cancerous cells in the body. These are generally molecules that are released due to the presence of a tumor or a particular indication in the body to the presence of cancer. These molecules are densely distributed in tissues, urine, serum, blood, and other body fluids. Their expression levels serve as the basis or indicat...Read More >>>

Published:
2016-12-01

Published by: Allied Market Research

Prices Starting From:
$5370

Published:
2016-11-25

Published by: MarketsandMarkets

Prices Starting From:
$5650

Cervical Dysplasia Market: By Type (low-grade SIL, or LSIL (Squamous Intraepithelial Lesion), high-grade SIL, or HSIL, Cancer Bound SIL, Atypical glandular cells (AGUS)) Strategic Analysis(Value Chain, Pricing Analysis, Others) & By Geography-Forecast (2016-2021) [Report Updated: 26-02-2016]

Cervical dysplasia is a precancerous medical condition generally found in women under age 30. Cervical dysplasia results in abnormal cell growth which occurs on the surface lining of the cervix or endocervical canal, the opening between the uterus and the vagina and sometimes is also called cervical intraepithelial neoplasia (CIN). Cervical dysplasia is strongly associated with sexually transmitte...Read More >>>

Published:
2016-02-26

Published by: Industry ARC

Prices Starting From:
$5250

Published:
2016-02-12

Published by: MarketsandMarkets

Prices Starting From:
$4650

Published:
2016-01-22

Published by: Industry ARC

Prices Starting From:
$5250

Additional Searches

You may also like to search separately for: Cervical Cancer

We Stock...

{STICKYFOOTERMOBILE}